Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 95
of 5Next
1:

Imbalanced effector and regulatory cytokine responses may underlie mycobacterial immune restoration disease.

Lim A, D'Orsogna L, Price P, French MA.

AIDS Res Ther. 2008 Apr 29;5:9.

PMID: 18442415 [PubMed]

2:

Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis.

Tan DB, Yong YK, Tan HY, Kamarulzaman A, Tan LH, Lim A, James I, French M, Price P.

HIV Med. 2008 May;9(5):307-16.

PMID: 18400078 [PubMed - in process]

3:

Immune restoration disease after antiretroviral therapy.

French MA, Price P, Stone SF.

AIDS. 2004 Aug 20;18(12):1615-27. Review.

PMID: 15280772 [PubMed - indexed for MEDLINE]

4:

Immune restoration disease: a consequence of dysregulated immune responses after HAART.

Stone SF, Price P, French MA.

Curr HIV Res. 2004 Jul;2(3):235-42. Review.

PMID: 15279587 [PubMed - indexed for MEDLINE]

5:

Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients.

Bourgarit A, Carcelain G, Martinez V, Lascoux C, Delcey V, Gicquel B, Vicaut E, Lagrange PH, Sereni D, Autran B.

AIDS. 2006 Jan 9;20(2):F1-7.

PMID: 16511406 [PubMed - indexed for MEDLINE]

6:

Levels of IL-6 and soluble IL-6 receptor are increased in HIV patients with a history of immune restoration disease after HAART.

Stone SF, Price P, Keane NM, Murray RJ, French MA.

HIV Med. 2002 Jan;3(1):21-7.

PMID: 12059947 [PubMed - indexed for MEDLINE]

7:

Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy.

Price P, Mathiot N, Krueger R, Stone S, Keane NM, French MA.

J Clin Virol. 2001 Oct;22(3):279-87.

PMID: 11564593 [PubMed - indexed for MEDLINE]

8:

[Tuberculosis in compromised hosts]

[No authors listed]

Kekkaku. 2003 Nov;78(11):717-22. Japanese.

PMID: 14672050 [PubMed - indexed for MEDLINE]

9:

Immune restoration disease in HIV-infected individuals receiving highly active antiretroviral therapy: clinical and immunological characteristics.

de Boer MG, Kroon FP, Kauffmann RH, Vriesendorp R, Zwinderman K, van Dissel JT.

Neth J Med. 2003 Dec;61(12):408-12.

PMID: 15025416 [PubMed - indexed for MEDLINE]

10:

Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals.

Lawn SD, Bekker LG, Miller RF.

Lancet Infect Dis. 2005 Jun;5(6):361-73. Review.

PMID: 15919622 [PubMed - indexed for MEDLINE]

11:

Immune restoration disease in HIV patients: aberrant immune responses after antiretroviral therapy.

French M, Price P.

J HIV Ther. 2002 May;7(2):46-51. Review.

PMID: 12553688 [PubMed - indexed for MEDLINE]

12:

Selected P. falciparum specific immune responses are maintained in AIDS adults in Burkina Faso.

Migot F, Ouedraogo JB, Diallo J, Zampan H, Dubois B, Scott-Finnigan T, Sanou PT, Deloron P.

Parasite Immunol. 1996 Jul;18(7):333-9.

PMID: 9229386 [PubMed - indexed for MEDLINE]

13:

Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases.

Price P, Morahan G, Huang D, Stone E, Cheong KY, Castley A, Rodgers M, McIntyre MQ, Abraham LJ, French MA.

AIDS. 2002 Oct 18;16(15):2043-7.

PMID: 12370503 [PubMed - indexed for MEDLINE]

14:

The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy.

Jevtović DJ, Salemović D, Ranin J, Pesić I, Zerjav S, Djurković-Djaković O.

HIV Med. 2005 Mar;6(2):140-3.

PMID: 15807721 [PubMed - indexed for MEDLINE]

15:

Increased Th1 and Th2 type cytokine production in patients with active tuberculosis.

Handzel ZT, Barak V, Altman Y, Bibi H, Lidgi M, Iancovici-Kidon M, Yassky D, Raz M.

Isr Med Assoc J. 2007 Jun;9(6):479-83.

PMID: 17642401 [PubMed - indexed for MEDLINE]

16:

Impaired IFN-gamma-secreting capacity in mycobacterial antigen-specific CD4 T cells during chronic HIV-1 infection despite long-term HAART.

Sutherland R, Yang H, Scriba TJ, Ondondo B, Robinson N, Conlon C, Suttill A, McShane H, Fidler S, McMichael A, Dorrell L.

AIDS. 2006 Apr 4;20(6):821-9.

PMID: 16549965 [PubMed - indexed for MEDLINE]

17:

M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy.

Shankar P, Agis F, Wallach D, Flageul B, Cottenot F, Augier J, Bach MA.

J Immunol. 1986 Jun 1;136(11):4255-63.

PMID: 2422278 [PubMed - indexed for MEDLINE]

18:

Varicella zoster as a manifestation of immune restoration disease in HIV-infected children.

Tangsinmankong N, Kamchaisatian W, Lujan-Zilbermann J, Brown CL, Sleasman JW, Emmanuel PJ.

J Allergy Clin Immunol. 2004 Apr;113(4):742-6.

PMID: 15100682 [PubMed - indexed for MEDLINE]

19:

Multiple Mycobacterium antigens induce interferon-gamma production from sarcoidosis peripheral blood mononuclear cells.

Carlisle J, Evans W, Hajizadeh R, Nadaf M, Shepherd B, Ott RD, Richter K, Drake W.

Clin Exp Immunol. 2007 Dec;150(3):460-8. Epub 2007 Oct 9.

PMID: 17924974 [PubMed - indexed for MEDLINE]

20:

Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy.

French MA, Lenzo N, John M, Mallal SA, McKinnon EJ, James IR, Price P, Flexman JP, Tay-Kearney ML.

HIV Med. 2000 Mar;1(2):107-15.

PMID: 11737333 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 95
of 5Next